Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotidesBrooke A. Anderson, Punit P. Seth, William J. Drury et al.|Nucleic Acids Research|2021Cited by 129
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta CellLaurent Knerr, Shalini Andersson, Thazha P. Prakash et al.|Journal of the American Chemical Society|2021Cited by 72